Amanda B. Pilling, Ph.D. - Publications

2011 Nutrition and Food Science Wayne State University, Detroit, MI, United States 
Nutrition, Oncology

2/7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Unnikrishnan A, Prychitko TM, Patel HV, Chowdhury ME, Pilling AB, Ventrella-Lucente LF, Papakonstantinou EV, Cabelof DC, Heydari AR. Folate deficiency regulates expression of DNA polymerase β in response to oxidative stress. Free Radical Biology & Medicine. 50: 270-80. PMID 21070850 DOI: 10.1016/J.Freeradbiomed.2010.11.003  0.52
2010 Ventrella-Lucente LF, Unnikrishnan A, Pilling AB, Patel HV, Kushwaha D, Dombkowski AA, Schmelz EM, Cabelof DC, Heydari AR. Folate deficiency provides protection against colon carcinogenesis in DNA polymerase beta haploinsufficient mice. The Journal of Biological Chemistry. 285: 19246-58. PMID 20404327 DOI: 10.1074/Jbc.M109.069807  0.52
Low-probability matches
2019 Pilling AB, Hwang C. Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide. The Prostate. PMID 31228231 DOI: 10.1002/pros.23843  0.01
2018 Pilling AB, Kim J, Estrada-Bernal A, Zhou Q, Le AT, Singleton KR, Heasley LE, Tan AC, DeGregori J, Doebele RC. ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer. Oncotarget. 9: 8823-8835. PMID 29507657 DOI: 10.18632/Oncotarget.24260  0.01
2017 Pilling AB, Hwang O, Boudreault A, Laurent A, Hwang C. IAP Antagonists Enhance Apoptotic Response to Enzalutamide in Castration-Resistant Prostate Cancer Cells via Autocrine TNF-α Signaling. The Prostate. PMID 28240376 DOI: 10.1002/pros.23327  0.01
2013 Vaishnavi A, Capelletti M, Le AT, Kako S, Butaney M, Ercan D, Mahale S, Davies KD, Aisner DL, Pilling AB, Berge EM, Kim J, Sasaki H, Park SI, Kryukov G, et al. Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer. Nature Medicine. 19: 1469-72. PMID 24162815 DOI: 10.1038/Nm.3352  0.01
2012 Doebele RC, Pilling AB, Aisner DL, Kutateladze TG, Le AT, Weickhardt AJ, Kondo KL, Linderman DJ, Heasley LE, Franklin WA, Varella-Garcia M, Camidge DR. Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 1472-82. PMID 22235099 DOI: 10.1158/1078-0432.Ccr-11-2906  0.01
Hide low-probability matches.